The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Monoclonal antibody to a triggering structure expressed on rat natural killer cells and adherent lymphokine-activated killer cells.
Open accessAbstract
To study the cellular structures involved in NK and lymphokine-activated killer (LAK) cell function, we have produced a panel of mAbs that modulate the cytolytic function of a population of cells with LAK activity that derive from large granular lymphocyte (LGL)/NK cells (adherent LAK [A-LAK] cells). In this report, we describe an mAb (3.2.3; IgG1k) that recognizes a triggering structure that is expressed on rat LGL/NK cells and A-LAK cells. This epitope is also expressed on polymorphonuclear leukocytes (PMN). The expression of the epitope identified by mAb 3.2.3 increased progressively on A-LAK cells after culture in the presence of rIL-2. mAb 3.2.3 enhanced the cytolytic activity of NK and A-LAK cells against FcR+ target cells, but not FcR- target cells. However, this effect was not induced by F(ab')2 fragments of 3.2.3. This antibody also induced the release of N-alpha-benzyloxycarbonyl-L-lysine thiobenzy esteresterase by A-LAK cells. These data suggest that the epitope identified by mAb 3.2.3 is on a triggering structure expressed on rat NK cells and A-LAK cells. The expression of the epitope recognized by mAb 3.2.3 on LGL/NK cells and PMN suggests that this structure may be analogous to that identified by the anti-CD16 (-FcR) mAbs. However, the molecule immunoprecipitated by mAb 3.2.3 was a 60-kD dimer composed of two 30-kD chains. These data suggest that mAb 3.2.3 recognizes a unique triggering structure. As mAb 3.2.3 is the first antibody recognizing a determinant with functional significance, selectively expressed on both rat NK cells and A-LAK cells, it will be a useful tool for the study of NK cell ontogeny and function, and the development of cells with LAK activity from the NK cell compartment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Grimm, E. A., Mazumder, A., Zhang, H. Z., & Rosenberg, S. A. (1982) · The Journal of experimental medicine · doi:10.1084/jem.155.6.1823 · Cited by 2,204
Lanier, L. L., Le, A. M., Phillips, J. H., Warner, N. L., & Babcock, G. F. (1983) · The Journal of Immunology · doi:10.4049/jimmunol.131.4.1789 · Cited by 847
Phillips, J. H., & Lanier, L. L. (1986) · The Journal of experimental medicine · doi:10.1084/jem.164.3.814 · Cited by 684
Human neutrophil Fc gamma receptor distribution and structure.
Fleit, H. B., Wright, S. D., & Unkeless, J. C. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.10.3275 · Cited by 564
A glycolipid on the surface of mouse natural killer cells
Kasai, M., Iwamod, M., Nagai, Y., Okumura, K., & Tada, T. (1980) · European Journal of Immunology · doi:10.1002/eji.1830100304 · Cited by 535
On the fragmentation of monoclonal IgG1, IgG2a, and IgG2b from BALB/c mice.
Parham, P. (1983) · The Journal of Immunology · doi:10.4049/jimmunol.131.6.2895 · Cited by 413
Perussia, B., Trinchieri, G., Jackson, A., Warner, N. L., Faust, J., Rumpold, H., Kraft, D., & Lanier, L. L. (1984) · The Journal of Immunology · doi:10.4049/jimmunol.133.1.180 · Cited by 328
Reynolds, C. W., Timonen, T., & Herberman, R. B. (1981) · The Journal of Immunology · doi:10.4049/jimmunol.127.1.282 · Cited by 282
Self-citationHercend, T., Griffin, J. D., Bensussan, A., Schmidt, R. E., Edson, M. A., Brennan, A., Murray, C., Daley, J. F., Schlossman, S. F., & Ritz, J. (1985) · Journal of Clinical Investigation · doi:10.1172/jci111794 · Cited by 265
Young, W. W., Hakomori, S., Durdik, J. M., et al. (1980) · The Journal of Immunology · doi:10.4049/jimmunol.124.1.199 · Cited by 220
Phenotypic and functional heterogeneity of human cloned natural killer cell lines
Hercend, T., Reinherz, E. L., Meuer, S., Schlossman, S. F., & Ritz, J. (1983) · Nature · doi:10.1038/301158a0 · Cited by 197
Hiserodt, J. C., Britvan, L. J., & Targan, S. R. (1982) · The Journal of Immunology · doi:10.4049/jimmunol.129.4.1782 · Cited by 175
Self-citationSpits, H., Yssel, H., Leeuwenberg, J. F. M., & de Vries, J. E. (1985) · European Journal of Immunology · doi:10.1002/eji.1830150117 · Cited by 172
Perussia, B., Acuto, O., Terhorst, C., Faust, J., Lazarus, R., Fanning, V, & Trinchieri, G. (1983) · The Journal of Immunology · doi:10.4049/jimmunol.130.5.2142 · Cited by 172
Vujanović, N. L., Herberman, R. B., Maghazachi, A. A., & Hiserodt, J. C. (1988) · The Journal of Experimental Medicine · doi:10.1084/jem.167.1.15 · Cited by 148
Self-citationNKP-15: A monoclonal antibody reactive against purified human natural killer cells and granulocytes
Phillips, J. H., & Babcock, G. F. (1983) · Immunology Letters · doi:10.1016/0165-2478(83)90096-2 · Cited by 136
Induction of nonspecific cytotoxicity by monoclonal anti-T3 antibodies.
Leeuwenberg, J. F. M., Spits, H., Tax, W. J. M., & Capel, P. J. (1985) · The Journal of Immunology · doi:10.4049/jimmunol.134.6.3770 · Cited by 126
Adoptive immunotherapy of cancer: accomplishments and prospects.
Rosenberg, S. A. (1984) · PubMed · Cited by 120
Antibody 3G8, specific for the human neutrophil Fc receptor, reacts with natural killer cells.
PERUSSIA, B., & Trinchieri, G. (1984) · The Journal of Immunology · doi:10.4049/jimmunol.132.3.1410 · Cited by 119
Yang, J. C., Mulé, J. J., & Rosenberg, S. A. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.137.2.715 · Cited by 109
van de Griend, R. J., Bolhuis, R. L. H., Stoter, G., et al. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.138.10.3137 · Cited by 82
A novel cytotoxic T lymphocyte activation assay
Takayama, H., Trenn, G., & Sitkovsky, M. V. (1987) · Journal of Immunological Methods · doi:10.1016/0022-1759(87)90502-3 · Cited by 59
Shau, H., & Golub, S. H. (1985) · The Journal of Immunology · doi:10.4049/jimmunol.134.2.1136 · Cited by 57
Schmidt, R. E., Hercend, T., Fox, D. A., et al. (1985) · The Journal of Immunology · doi:10.4049/jimmunol.135.1.672 · Cited by 54
Hiserodt, J. C., Laybourn, K. A., & Varani, J. (1985) · The Journal of Immunology · doi:10.4049/jimmunol.135.2.1484 · Cited by 51
Self-citationEnhancement of natural killer function through activation of the T11 E rosette receptor.
Schmidt, R. E., Michon, J. M., Woronicz, J. D., et al. (1987) · Journal of Clinical Investigation · doi:10.1172/jci112800 · Cited by 45
Induction of natural killer‐like cytotoxicity in cultured human thymocytes
Toribio, M. L., Landázuri, M. O., & López‐Botet, M. (1983) · European Journal of Immunology · doi:10.1002/eji.1830131203 · Cited by 42
TORTEN, M., Sidell, N., & Golub, S. H. (1982) · The Journal of Experimental Medicine · doi:10.1084/jem.156.5.1545 · Cited by 36
Hiserodt, J. C., Laybourn, K. A., & Varani, J. (1985) · PubMed · Cited by 30
Self-citationThe effects of hexose 6-O-sulfate esters on human natural killer cell lytic function.
Chambers, W. H., & Oeltmann, T. N. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.137.5.1469 · Cited by 13
Self-citation
Cited by
Lanier, L. L. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.359 · Cited by 1,648
Recruitment of Tyrosine Phosphatase HCP by the Killer Cell Inhibitory Receptor
Burshtyn, D. N., Scharenberg, A. M., Wagtmann, N., Rajagopalan, S., Berrada, K., Yi, T., Kinet, J.-P., & Long, E. O. (1996) · Immunity · doi:10.1016/s1074-7613(00)80300-3 · Cited by 613
Immune functions encoded by the natural killer gene complex
Yokoyama, W. M., & Plougastel, B. F. M. (2003) · Nature Reviews Immunology · doi:10.1038/nri1055 · Cited by 565
Yokoyama, W. M., & Seaman, W. E. (1993) · Annual Review of Immunology · doi:10.1146/annurev.iy.11.040193.003145 · Cited by 461
Houchins, J. P., Yabe, T., McSherry, C., & Bach, F. H. (1991) · The Journal of experimental medicine · doi:10.1084/jem.173.4.1017 · Cited by 447
Metadata
- Authors
- Chambers, W. H., Vujanovic, N. L., DeLeo, A. B., Olszowy, M. W., Herberman, R. B., & Hiserodt, J. C.
- Venue
- The Journal of experimental medicine
- Publisher
- Rockefeller University Press
- Published
- 1989-04-01
- Volume
- 169
- Issue
- 4
- Pages
- 1373-1389
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2157528499
- Cited by
- 359
- References
- 30
- FWCI
- 6.30
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.